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The results of genetic linkage studies for autism have suggested that a susceptibility locus for the disease is located
on the long arm of chromosome 7 (7q). An autistic individual carrying a translocation, t(7;13)(q31.3;q21), with
the chromosome 7 breakpoint located in the region of 7q implicated by genetic studies was identified. A novel gene
known as “RAY1” (or “FAM4A1”) was found to be directly interrupted by the translocation breakpoint. The gene,
which was found to be encoded by 16 exons with evidence of alternative splicing, spanned 220 kb of DNA at
7q31.3. Mutation screening of the entire coding region in a set of 27 unrelated autistic individuals failed to identify
phenotype-specific variants, suggesting that coding region mutations are unlikely to be involved in the etiology of
autism. Apparent homologues of RAY1 have also been identified in mouse, rat, pig, chicken, fruit fly, and nematode.
The human and mouse genes share similar splicing patterns, and their predicted protein products are 98% identical.
Autism, or autistic disorder (AD [MIM 209850]), a se-
vere and debilitating developmental disorder with onset
in childhood, is characterized by impaired communi-
cation and social interaction coupled with preoccupa-
tions, repetitive and ritualistic behaviors, and a restricted
pattern of interests and activities. The prevalence of typ-
ical autism has been estimated to be 5.5/10,000 (Fom-
bonne 1999), whereas a broader phenotype of autism-
spectrum disorders has a population prevalence of 18.7/
10,000 (Fombonne 1999). The contribution of genetic
factors to autism is well established, but the mode of
genetic transmission is unclear. Results from the first
genomewide scan for linkage to autism were published
(International Molecular Genetic Study of Autism Con-
sortium [IMGSAC] 1998), and regions on six chromo-
somes (chromosomes 4, 7, 10, 16, 19, and 22) with
multipoint maximum LOD scores (MLS) of 11 were
identified. As shown in figure 1, themost significantMLS
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(3.55) was found with genetic markers residing on the
long arm of chromosome 7 (7q). Results from other
genome scans have also suggested that 7q might contain
a putative autism-susceptibility locus (fig. 1; Ashley-
Koch et al. 1999; Barrett et al. 1999; Philippe et al.
1999), with some evidence to suggest maternal imprint-
ing at the locus (Ashley-Koch et al. 1999). Linkage re-
sults for a severe speech and language disorder have also
implicated a locus (SPCH1 [MIM 602081]) within the
same general region of 7q (Fisher et al. 1998).
A patient with autism who had a translocation,
t(7;13)(q31.2;q21), involving the implicated region of
7q was identified. The translocation was transmitted
by an unaffected mother. Diagnosis of the patient, a
12-year-old boy, was made by use of DSM-IIIR di-
agnostic criteria for autism, using the Autism Diag-
nostic Interview (Le Couteur et al. 1989) and the Au-
tism Diagnostic Observational Schedule (Lord et al.
1989). Following the hypothesis that the translocation
might disrupt an autism-susceptibility gene, we
mapped the site of the breakpoint by use of FISH
analysis of metaphase spreads from a lymphoblastoid
cell line from the patient. A bacterial-artificial-chro-
mosome (BAC) clone (H_RG114A06 [GenBank ac-
cession number AC002542]) that spanned the break-
point was identified. By use of exon-specific cosmid
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Figure 1 Ideogram of the long arm of chromosome 7 indicating the relative positions of positive linkage results from genome scans for
autism and severe speech and language disorder (from Barrett et al. 1999 [A]; Fisher et al. 1998 [B; for SPCH1]; IMGSAC 1998 [C]; Philippe
et al. 1999 [D]; Ashley-Koch et al. 1999 [E]; and Barrett et al. 1999 [F]). The position of RAY1 and the translocation breakpoint for
t(7;13)(q31.2;q21), relative to neighboring genes and DNA markers, is also shown. RAY1 contains 16 exons and spans two BAC clones and
one PAC clone. Exon 7 is alternatively spliced, and alternate 3′ terminal exons (16a or 16b), are employed in different transcripts. The translocation
breakpoint probably occurs between exons 9 and 10 (cosmid clone 14c9 is translocated and 172d6 is not translocated). The relative positions
of the CpG island, antisense transcript Hs. 131046, and the 139-bp palindrome are also shown. The end sequences of cosmids cos14c9, cos
19d10, cos172d6, and BAC H_NH0032P06 were generated, which allowed them to be aligned to the existing genomic sequence.
probes for the gene described below, the translocation
breakpoint could be positioned between exons 9 and
10. Of interest is the fact that this region contains an
almost perfectly symmetrical palindromic sequence
that is 139 bp long (nucleotides 126287–126425).
Nonhomologous recombination at a high frequency
has been observed for palindromic transgenes in mice
(Akgun et al. 1997). Thus, it is conceivable that this
sequence may be the actual position of the translo-
cation breakpoint in this individual. Spectral karyo-
typing was also performed, and the results lent further
support to the conclusion that additional rearrange-
ments were not present (data not shown). Clone
H_RG114A06 was localized within the 7q critical re-
gion for linkage for autism, just proximal to CFTR
and between genes WNT2 and CAPZA2 (fig. 1).
A combination of DNA sequence analysis and cDNA
library screening was used to clone a gene that spanned
the breakpoint. In brief, the expressed-sequence-tag
(EST) clone IMAGE #724082 (Research Genetics),
which mapped to H_RG114A06, was used to screen a
human colon carcinoma cDNA library and a human
fetal brain cDNA library. Through alignment of the
cDNA sequence to the genomic DNA sequence, it was
possible to identify a gene that consisted of 16 exons
and spanned 220 kb. This gene has been named
“RAY1” (“FAM4A1” [approved by the HumanGenome
Organization nomenclature committee]; GenBank ac-
cession numbers AF234882 and AF234883). Alterna-
tively spliced transcripts differing at exon 7 and having
two different exon 16s, to give transcripts of 2,047–
2,760 bp with corresponding predicted open reading
frames (ORFs) of 554–585 amino acids, respectively,
have been identified. Two additional exons, which have
been identified in ESTs (IMAGE #1840889 [GenBank
accession number AI221163] and IMAGE #1628386
[GenBank accession number AI018574]) but not in full-
length clones, lie at nucleotides 162185–162390 and
162922–162994 (H_RG114A06) between exons 12
and 13. Exon 1 was found to be upstream of clone
H_RG114A06, on BAC clone H_NH0032P06, which
bridges the gap between BAC clones H_RG114A06 and
H_RG300C03. This positions exon 1 at 90–150 kb up-
stream of exon 2 (fig. 1). A cosmid clone (cos19d10)
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Figure 2 Amino acid sequence alignment for cloned humanRAY1
(FAM4A1), mouse mray (Fam4a1), and the deduced D. melanogaster
(fruit fly) and C. elegans (nematode) genes dray and nray. The D. me-
lanogaster gene was deduced by analysis of genomic clone CDM:
10211043 (GenBank accession number AC014350), by use of GEN-
SCAN, and from EST clones (GenBank accession numbers AA438606
and AA949923). The C. elegans gene sequence was deduced by analysis
of genomic clone CEF11A10 (GenBank accession number Z68297), by
use of FGENES, and from EST sequences (GenBank accession numbers
C45487, C40736, C34292 and M80024). 5′ mRNAs (GenBank acces-
sion numbers AW360118 and AW436819) for a pig homologue were
also identified; taken together, they encode for 241 N-terminal amino
acids, which are identical to 240 of the first 242 amino acids of the
human sequence. A rat EST clone (GenBank accession number
AW141348) encodes the 3′ end of the gene, which is 100% identical to
the human C-terminal 120 amino acids.
containing exon 1 was isolated, and, through DNA se-
quencing of subclones, 2.1 kb of sequence flanking exon
1 (GenBank accession number AF234886) were deter-
mined, including a CpG island, a TATA box, and pu-
tative promoter sequences.
The human gene was also used to screen amouse brain
cDNA library, from which a mouse homologue, mray
(Fam4a1 [GenBank accession numbers AF234884 and
AF234885]), was cloned. The mouse homologue, which
also demonstrates alternative splicing of exon 7 (assum-
ing the same exon structure as human RAY1), has tran-
script lengths of 2,165 and 2,180 bp with corresponding
predicted ORFs of 511 and 534 amino acids. Homology
with the human protein is 198%. RAY1 and mray also
correspond to a putative Caenorhabditis elegans gene,
which encodes an ORF with 534 amino acids, and to a
putative Drosophila gene, which has an ORF of 538
amino acids. The predicted C. elegans protein is 48%
homologous to RAY1 and 46% homologous to mray,
whereas the predicted Drosophila protein is 68% ho-
mologous to RAY1 and 66% homologous to mray (fig.
2).
RAY1 is expressed in a wide range of tissues but is most
abundant in the heart, liver, and pancreas (transcript∼2.4
kb; fig. 3). The amino acid sequences of RAY1 and mray
show no significant homology with any proteins in the
database (SWISSPROT and PDB), and no consistent mo-
tifs were observed when protein analysis programs (Pfam,
BLOCKS, ProDom, PRINTS, prosite pattern, and prosite
profile) were used.
A second gene, identified from ESTs from Unigene
cluster Hs. 131046, is situated adjacent to RAY1 and is
transcribed on the opposite strand, overlapping exon 1,
just upstream of the AUG start site (nucleotide 1423;
GenBank accession number AF234886). The 5′ end of
the transcript starts at nucleotide 1252, and polyade-
nylation starts after either nucleotide 328 or nucleotide
456 (GenBank accession number AF234886). No sig-
nificant ORF occurs in this transcript, possibly suggest-
ing that this represents the 3′ UTR of a coding gene, the
coding portion of which is situated in the unsequenced
portion of intron 1. Alternatively, this transcript may be
a noncoding RNA—possibly a riboregulator—involved
in control of translation of the gene on the sense
strand—namely, RAY1.
The reciprocal half of the translocation breakpoint
on 13q21 was localized within CEPH YACs 925e11
and 857h4, which encompass the genetic markers
CHLC.GATA42A09 and AFM311wd5 (to date, no tran-
scripts are known to map within this BAC clone). In-
terestingly, an MLS of 3.0 was demonstrated for the
marker D13S800 in a study by the Collaborative Link-
age Study of Autism (Barrett et al. 1999), which also
implicates this region in autism. D13S800 resides 15.5
cM distal to the translocation breakpoint on the female
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Figure 3 Multiple-tissue northern blot (Clontech) for human
RAY1, for selected tissues: heart (a), brain (b), placenta (c), lung (d),
liver (e), skeletal muscle (f), kidney (g), and pancreas (h). A 2.4-kb
transcript is abundant in most tissues—in particular, the heart, liver,
and pancreas. A less abundant but slightly larger transcript can be
seen for brain (∼2.5 kb), and larger transcripts (∼2.8 kb) are also
present in the heart and the placenta, in addition to the 2.4-kb
transcript.
recombination map but is as close as 0.44 cM on the
male recombination map (Genetic Location Database).
The serotonin receptor HTR2A (MIM 182135) lies ∼3
cM proximal to the translocation (1.54 cMon the female
map). Involvement of the serotonin system has long been
suspected in autism, and secondary serotonin reuptake
inhibitors are commonly used to treat a number of symp-
toms of autism.
The RAY1 gene was screened for mutations in DNA
from 33 individuals with autism who were from 23 mul-
tiplex families and from 4 unrelated probands (primer
sequences and PCR conditions are posted at The Chro-
mosome 7 Project Web site or are available from the
authors on request). Ascertainment and diagnostic cri-
teria for the families were those described by Bolton et
al. (1992). Each exon was screened using cycle sequenc-
ing (USB) in forward and reverse. No patient-specific
variants were found, although several polymorphisms
were observed, including a TrC polymorphism in intron
10, located 7 bp downstream from the donor-splice site
(GenBank accession number AC002542; nucleotide
134833), and a TrC polymorphism in intron 11, lo-
cated 16 bp downstream from the exon 11 donor-splice
site (GenBank accession number AC002542; nucleotide
153259).
PCR followed by restriction digestion with StyI was
used to analyze the frequency of the intron 10 poly-
morphism, and allele-specific oligonucleotide hybridi-
zation (T allele, 5′-AAT AGT TTG CGC G-3′; C allele,
5′-AAT AGC TTG CGC G-3′) was used to determine
allele frequencies for the intron 11 variant in the pro-
bands with autism and a population of unrelated, un-
affected individuals ( ). No allelic associationwithN = 88
autism was observed (exon 10 , ; exon 112x = 0 P = 1
, ), and there was no apparent segre-2x = 0.26 P = .61
gation with autism in the 23 families genotyped.
The findings presented here suggest that disruption or
mutation at RAY1 may not be directly involved in the
etiology of autism and that the translocation in this pa-
tient is purely coincidental. However, it would be pre-
mature to exclude this region, because other transcripts
may either overlap RAY1 or be transcribed from the
opposite strand. Also, further mutation screening of
RAY1 may be required in additional patients, to exclude
it as a rare cause of autism. There exists the further
possibility that a mutation or variant at RAY1may have
a more subtle effect as a risk factor for autism, requiring
the action of other genes for phenotypic expression. To
demonstrate this, disequilibrium studies in a much larger
sample with autism may be required.
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